1887
Preview this article:

There is no abstract available.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/00222615-33-4-207
1990-12-01
2022-08-16
Loading full text...

Full text loading...

/deliver/fulltext/jmm/33/4/medmicro-33-4-207.html?itemId=/content/journal/jmm/10.1099/00222615-33-4-207&mimeType=html&fmt=ahah

References

  1. Bartlett JG, Chang T-W, Gurwith M, Gorbach SL, Onderdonk AB. Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. N Engl JMed 1978; 298:531–534
    [Google Scholar]
  2. George RH, Symonds JM, Dimock F. et al. Identification of Clostridium difficile as a cause of pseudomembranous colitis. Br MedJ 1978; 1:965
    [Google Scholar]
  3. Larson HE, Price AB, Honour P, Borriello SP. Clostridium difficile and the aetiology of pseudomembranous colitis. Lancet 1978; I:1063–1066
    [Google Scholar]
  4. Butzler JP, Dekeyser P, Detrain M, Dehaen F. Related vibrio in stools. J Pediatr 1973; 82:493–495
    [Google Scholar]
  5. Larson HE, Parry JV, Price AB, Davies PR, Dolby J, Tyrrell DAJ. Undescribed toxin in pseudomembranous colitis. Br MedJ 1977; 1:1246–1248
    [Google Scholar]
  6. Bartlett JG. Introduction. In Rolfe RD, Finegold SM. (eds) Clostridium difficile: its role in intestinal disease San Diego: Academic Press; 1988; 1
    [Google Scholar]
  7. Bartlett JG, Onderdonk AB, Cisneros RL, Kasper DL. Clindamycin-associated colitis due to a toxin-producing species of Clostridium in hamsters. J Infect Dis 1977; 136:701–705
    [Google Scholar]
  8. Hall IC, O’Toole E. Intestinal flora in new-born infants, with description of new pathogenic anaerobe, Bacillus difficilis. Am J Dis Child 1935; 49:390–402
    [Google Scholar]
  9. Snyder ML. Normal fecal flora of infants between two weeks and one year of age. J Infect Dis 1940; 66:1–16
    [Google Scholar]
  10. Hafiz S, Oakley CL. Clostridium difficile: isolation and characteristics. J Med Microbiol 1976; 9:129–136
    [Google Scholar]
  11. Hammarström S, Perlmann P, Gustafsson BE, Lagercrantz R. Autoantibodies to colon in germfree rats monocontaminated with Clostridium difficile. J Exp Med 1969; 129:747–756
    [Google Scholar]
  12. Burdon DW. Spectrum of disease. In Borriello SP. (ed) Antibiotic associated diarrhoea and colitis (Developments in gastroenterology 5) Boston: Martinus Nijhoff; 1984; 9
    [Google Scholar]
  13. Borriello SP, Barclay FE, Welch AR. et al. Host and microbial determinants of the spectrum of Clostridium difficile-meàidXQà gastrointestinal disorders. In Erland-ser SL, Jordan MC, Wells CL, Rusch V. (eds) Microecology and therapy vol 15 Herbom-Dill: Institute for Microecology; 1985231
    [Google Scholar]
  14. Larson HE, Price AB, Borriello SP. Epidemiology of experimental enterocecitis due to Clostridium difficile. J Infect Dis 1980; 142:408–413
    [Google Scholar]
  15. Borriello SP, Barclay FE. An in-vitro model of colonisation resistance to Clostridium difficile infection. J Med Microbiol 1986; 21:299–309
    [Google Scholar]
  16. Borriello SP, Barclay FE, Welch AR. Evaluation of the predictive capability of an in-vitro model of colonisation resistance to Clostridium difficile infection. Microb EcolHlth Dis 1988; 1:61–64
    [Google Scholar]
  17. Larson HE, Borriello SP. Quantitative study of antibiotic induced susceptibility to Clostridium difficile enterocecitis in hamsters. Antimicrob Agents Chemother 1990; 34:1348–1353
    [Google Scholar]
  18. Bartlett JG, Tedesco FJ, Shull S, Lowe B, Chang T-W. Symptomatic relapse after oral vancomycin therapy of antibiotic-associated pseudomembranous colitis. Gastroenterology 1980; 78:431–434
    [Google Scholar]
  19. Schwan A, Sjolin S, Trottestam U, Aronsson B. Relapsing Clostridium difficile enterocolitis cured by rectal infusion of normal faeces. ScandJ Infect Dis 1984; 16:211–215
    [Google Scholar]
  20. Tvede M, Rask-Madsen J. Bacteriotherapy for chronic relapsing Clostridium difficile diarrhoea in six patients. Lancet 1989; 1:1156–1160
    [Google Scholar]
  21. Gorbach SL. Lactic acid bacteria and human health. Ann Med 1990; 22:37–41
    [Google Scholar]
  22. Elmer GW, Surawicz CM, McFarland LV, Chinn J. An open trial of vancomycin plus Saccharomyces boulardii for the treatment of relapsing Clostridium difficile diarrhoea/colitis. In Dougherty SH, Hentges DJ, Lyerly DM, Rolfe RD, Rusch VC, Walker RI. (eds) Microecology and therapy vol 19 Herbom-Dill: Institute for Microecology; 1989251
    [Google Scholar]
  23. Seal D, Borriello SP, Barclay FE, Welch A, Piper M, Bonnycastle M. Treatment of relapsing Clostridium difficile diarrhoea by administration of a non-toxigenic strain. Eur J Clin Microbiol 1987; 6:51–53
    [Google Scholar]
  24. Borriello SP, Barclay FE. Protection of hamsters against Clostridium difficile ileocaecitis by prior colonisation with non-pathogenic strains. J Med Microbiol 1985; 19:339–350
    [Google Scholar]
  25. Borriello SP. The application of bacterial antagonisms in the prevention and treatment of Clostridium difficile infection of the gut. In Hardie JM, Borriello SP. (eds) Anaerobes today Chichester: John Wiley and Sons; 1988195
    [Google Scholar]
  26. Borriello SP. Influence of the normal flora of the gut on Clostridium difficile . In Grubb R, Midvedt T, Norin E. (eds) The regulatory and protective role of the normal microflora Basingstoke: MacMillan Press; 1989239
    [Google Scholar]
  27. Borriello SP. The influence of the normal floraon Clostridium difficile colonisation of the gut. Ann Med 1990; 22:61–67
    [Google Scholar]
  28. Aronsson B, Granström M. Immunological response to Clostridium difficile infection. In Rolfe RD, Finegold SM. (eds) Clostridium difficile: its role in intestinal disease San Diego: Academic Press; 198899
    [Google Scholar]
  29. Peach SL, Borriello SP, Gaya H, Barclay FE, Welch AR. Asymptomatic carriage of Clostridium difficile in patients with cystic fibrosis. J Clin Pathol 1986; 39:1013–1018
    [Google Scholar]
  30. Borriello SP, Barclay FE. Colonisation resistance to Clostrid ium difficile infection. In Rusch VC. (ed) Microecology and therapy vol 14 Herbom-Dill: Institute for Microecology; 198475
    [Google Scholar]
  31. Borriello SP. Clostridium difficile and its toxin in the gastrointestinal tract in health and disease. Res Clin Forums 1979; 1:33–35
    [Google Scholar]
  32. Libby JM, Donta ST, Wilkins TD. Clostridium difficile toxin A in infants. J Infect Dis 1983; 148:606
    [Google Scholar]
  33. Rolfe RD, Iaconis JP. Intestinal colonization of infant hamsters with Clostridium difficile. Infect Immun 1983; 42:480–486
    [Google Scholar]
  34. Borriello SP, Davies HA, Kamiya S, Reed PJ, Seddon S. Virulence factors of Clostridium difficile. Rev Infect Dis 1990; 12: Suppl 2S185–S191
    [Google Scholar]
  35. Lyerly DM, Saum KE, MacDonald DK, Wilkins TD. Effects of Clostridium difficile toxins given intragastric-ally to animals. Infect Immun 1985; 47:349–352
    [Google Scholar]
  36. Mitchell TJ, Ketley JM, Haslam SC. et al. The effect of toxins A and B of Clostridium difficile on rabbit ileum and colon. Gut 1986; 27:78–85
    [Google Scholar]
  37. Krivan HC, Clark GF, Smith DF, Wilkins TD. Cell surface binding site for Clostridium difficile enterotoxin: evidence for a glycoconjugate containing the sequence Galal-3Galβl-4GlcNAc. Infect Immun 1986; 53:573–581
    [Google Scholar]
  38. Krivan HC, Wilkins TD. Purification of Clostridium difficile toxin A by affinity chromatography on immobilized thyroglobulin. Infect Immun 1987; 55:1873–1877
    [Google Scholar]
  39. Kamiya S, Reed PJ, Borriello SP. Analysis of purity of Clostridium difficile toxin A derived by affinity chromatography on immobilized bovine thyroglobulin. FEMS Microbiol Lett 1988; 56:331–336
    [Google Scholar]
  40. Kamiya S, Reed PJ, Borriello SP. Purification and charac terisation of Clostridium difficile toxin A by bovine thyroglobulin affinity chromatography and dissociation in denaturing conditions with or without reduction. J Med Microbiol 1989; 30:69–77
    [Google Scholar]
  41. Borriello SP, Ketley JM, Mitchell TJ. et al. Clostridium difficile—a spectrum of virulence and analysis of putative virulence determinants in the hamster model of antibiotic-associated colitis. J Med Microbiol 1987; 24:53–64
    [Google Scholar]
  42. Borriello SP, Welch AR, Barclay FE, Davies HA. Mucosal association by Clostridium difficile in the hamster gastrointestinal tract. J Med Microbiol 1988; 25:191–196
    [Google Scholar]
  43. Twomenen E, Weiss A, Rich R, Zak S, Zak O. Filamentous haemagglutinin and pertussis toxin promote adherence of Bordetella pertussis to cilia. Dev Biol Stand 1985; 61:197–204
    [Google Scholar]
  44. Borriello SP, Davies HA, Barclay FE. Detection of fimbriae amongst strains of Clostridium difficile. FEMS Microbiol Lett 1988; 49:65–67
    [Google Scholar]
  45. Seddon SV, Hemingway I, Borriello SP. Hydrolytic enzyme production by Clostridium difficile and its relationship to toxin production and virulence in the hamster model. J Med Microbiol 1990; 31:169–174
    [Google Scholar]
  46. Wilson KH, Perini F. Role of competition for nutrients in suppression of Clostridium difficile by the colonic microflora. Infect Immun 1988; 56:2610–2614
    [Google Scholar]
  47. Dailey DC, Kaiser A, Schloemer RH. Factors influencing the phagocytosis of Clostridium difficile by human polymorphonuclear leucocytes. Infect Immun 1987; 55:1541–1546
    [Google Scholar]
  48. Davies HA, Borriello SP. Detection of capsule in strains of Clostridium difficile . Microb Pathog 1990 (in press)
    [Google Scholar]
  49. Lima AAM, Lyerly DM, Wilkins TD, Innes DJ, Guerrant RL. Effects of Clostridium difficile toxins A and B in rabbit small and large intestine in vivo and on cultured cells in vitro. Infect Immun 1988; 56:582–588
    [Google Scholar]
  50. Seddon S, Borriello SP. Proteolytic activity of Clostridium difficile . J Med Microbiol 1990 (in press)
    [Google Scholar]
  51. Corthier G, Muller MC, Elmer GW, Lucas F, Dubos-Ramare F. Relationship between proteolytic activities, and production of toxin during Clostridium difficile—induced cecitis in gnotobiotic mice. In Dougherty SH, Hentges DJ, Lyerly DM, Rolfe RD, Rusch VC, Walker RI. (eds) Microecology and therapy vol 19 Herborn-Dill: Institute for Microecology; 1989217
    [Google Scholar]
  52. Borriello SP. Concluding remarks—the unanswered ques tions. In Borriello SP. (ed) Antibiotic associated diarrhoea and colitis (Developments in gastroenterology 5) Boston: Martinus Nijhoff; 1984147
    [Google Scholar]
  53. Rolfe RD, Finegold SM. Conclusions and unanswered questions. In Rolfe RD, Finegold SM. (eds) Clostridium difficile: its role in intestinal disease San Diego: Academic Press; 1988383
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/00222615-33-4-207
Loading
/content/journal/jmm/10.1099/00222615-33-4-207
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error